Jaimin Shah

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 79 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Eculizumab improves fatigue in refractory generalized myasthenia gravis

Henning Andersen, Renato Mantegazza, Jing Jing Wang et al. · Quality of Life Research · 2019 · 56 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Elevated methylation levels, reduced expression levels, and frequent contractions in a clinical cohort of C9orf72 expansion carriers

Jazmyne L. Jackson, NiCole A. Finch, Matthew Baker et al. · Molecular Neurodegeneration · 2020 · 53 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Single-cell profiling of the human primary motor cortex in ALS and FTLD

S. Sebastian Pineda, Hyeseung Lee, Brent E. Fitzwalter et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 42 citations · Full text

Life Sciences, Neurology, Neuroscience +15